US EditionPublished • loading... • Updated
HonorHealth Research Institute announces first patient dosed with new stroke treatment - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
HonorHealth Research Institute announces first patient dosed with new stroke treatment - Pharmafile
HonorHealth Research Institute, a research institution collaborating with a wide range of experts to produce new treatments and devices, has announced the first patient dosed with BB-031, an investigational stroke treatment. BB-031 works to target platelets, rather than the clotting proteins usually targeted by stroke treatments, in order to reopen blocked blood vessels in the […] The post HonorHealth Research Institute announces first patient d…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
